Wegovy commonly causes nausea, particularly during dose escalation, whilst stimulants can cause gastrointestinal upset in some individuals
For clinicians, staying informed about evolving regulations will be essential over the next several years
More widespread use of SGLT2i in type 1 diabetes will necessitate implementation of strategies to assess and mitigate DKA risk, including preventative measures, patient education and continuous ketone monitoring, as well as a better understanding of the potential benefits for clinical cardiorenal outcomes, especially in high-risk populations such as people with CKD (Table 2) [46, 47]
BPC-157 SKU BPC-157 is a peptide chain consisting of 15 amino acids and is also known as "body protecting compound." BPC-157 is also known as PL 14736, and Bepecin
Long-Term Safety Considerations When using semaglutide for an extended period, its essential to consider the treatments long-term safety